Geovax Labs Risk Profile Appears Stable, But Investors Should Watch for Emerging SEC-Disclosed PressuresTip Ranks·Jul 29 at 01:00 AMGOVX-2.65%GOVXW0.00%
GeoVax Labs, Inc. 2026: Revenue $0 EPS ($0.97) — 10-Q SummaryTradingView·Jul 27 at 03:41 PMGOVX-2.65%GOVXW0.00%
GeoVax Q2 FY26 net loss narrows to $4.43 million, or $0.97 a share; revenue posts no revenuePUBT·Jul 27 at 03:34 PMGOVXW0.00%GOVX-2.65%
Pre-market hot trades in US stocks: GeoVax Labs up 10.76% in pre-market; Banco Santander SA-Spon up 3.90% in pre-marketPrice Alert·Jul 27 at 05:57 AMGOVX-2.65%SAN+1.17%
GeoVax gets Nasdaq notice for failing $2.5 million stockholders’ equity requirementPUBT·Jul 10 at 03:06 PMGOVXW0.00%GOVX-2.65%
Divergent Signals in an Unclassified Cohort: Cross-Border Catalysts and Downside Risks Across 42 EquitiesGlobal Report·Jun 18 at 08:18 AMHNST-1.03%FRO-2.57%
GeoVax Labs shareholders approve Wipfli as independent auditor for 2026PUBT·Jun 17 at 03:33 PMGOVXW0.00%GOVX-2.65%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jun 1 at 07:06 AMGOVX-2.65%AIM+7.83%
Pre-market hot trades in US stocks: GeoVax Labs pre-market down 8.31%; Firefly Aerospace pre-market up 8.30%Price Alert·May 27 at 04:22 AMGOVX-2.65%FLY-2.10%
Top Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On Watchnasdaq·May 26 at 03:00 AMAKTX-3.72%SLGL+4.15%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·May 22 at 07:06 AMQTEX+2.86%MTVA+2.05%
Biotech Stock Gainers: CODX Extends Rally, SBFM Surges, GOVX Ebola Strategy, RGNX Awaits Catalystsrttnews·May 21 at 09:40 PMAKTX-3.72%PIII-2.02%
